ARCOSA INC (ACA) Stock Fundamental Analysis
USA - NYSE:ACA - US0396531008 - Common Stock
94.51 USD
+1.45 (+1.56%)
We assign a fundamental rating of 5 out of 10 to ACA. ACA was compared to 55 industry peers in the Construction & Engineering industry. ACA has an average financial health and profitability rating. ACA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ACA had positive earnings in the past year.
ACA had a positive operating cash flow in the past year.
ACA had positive earnings in each of the past 5 years.
ACA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ACA has a Return On Assets of 1.84%. This is comparable to the rest of the industry: ACA outperforms 47.27% of its industry peers.
Looking at the Return On Equity, with a value of 3.68%, ACA is doing worse than 60.00% of the companies in the same industry.
ACA's Return On Invested Capital of 4.09% is in line compared to the rest of the industry. ACA outperforms 45.45% of its industry peers.
ACA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is significantly below the industry average of 17.10%.
The 3 year average ROIC (3.99%) for ACA is below the current ROIC(4.09%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 3.68% | ||
| ROIC | 4.09% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
With a Profit Margin value of 3.45%, ACA perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
ACA's Profit Margin has declined in the last couple of years.
ACA has a better Operating Margin (8.93%) than 69.09% of its industry peers.
ACA's Operating Margin has declined in the last couple of years.
ACA's Gross Margin of 20.82% is fine compared to the rest of the industry. ACA outperforms 63.64% of its industry peers.
ACA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.93% | ||
| PM (TTM) | 3.45% | ||
| GM | 20.82% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACA is destroying value.
Compared to 1 year ago, ACA has more shares outstanding
Compared to 5 years ago, ACA has more shares outstanding
The debt/assets ratio for ACA is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.16 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACA has a Altman-Z score (2.16) which is in line with its industry peers.
ACA has a debt to FCF ratio of 5.72. This is a neutral value as ACA would need 5.72 years to pay back of all of its debts.
ACA has a Debt to FCF ratio of 5.72. This is comparable to the rest of the industry: ACA outperforms 56.36% of its industry peers.
ACA has a Debt/Equity ratio of 0.67. This is a neutral value indicating ACA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.67, ACA perfoms like the industry average, outperforming 52.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 5.72 | ||
| Altman-Z | 2.16 |
ROIC/WACC0.43
WACC9.58%
2.3 Liquidity
A Current Ratio of 2.12 indicates that ACA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.12, ACA belongs to the best of the industry, outperforming 89.09% of the companies in the same industry.
A Quick Ratio of 1.35 indicates that ACA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.35, ACA is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 2.62% over the past year.
Measured over the past 5 years, ACA shows a small growth in Earnings Per Share. The EPS has been growing by 5.16% on average per year.
Looking at the last year, ACA shows a quite strong growth in Revenue. The Revenue has grown by 9.78% in the last year.
ACA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.15% yearly.
EPS 1Y (TTM)2.62%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%39.56%
Revenue 1Y (TTM)9.78%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%10.86%
3.2 Future
Based on estimates for the next years, ACA will show a very strong growth in Earnings Per Share. The EPS will grow by 22.40% on average per year.
Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 6.56% on average per year.
EPS Next Y33.6%
EPS Next 2Y26.07%
EPS Next 3Y22.4%
EPS Next 5YN/A
Revenue Next Year10.2%
Revenue Next 2Y8.19%
Revenue Next 3Y6.56%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 30.19, ACA can be considered very expensive at the moment.
ACA's Price/Earnings ratio is a bit cheaper when compared to the industry. ACA is cheaper than 67.27% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.83. ACA is around the same levels.
Based on the Price/Forward Earnings ratio of 19.76, the valuation of ACA can be described as rather expensive.
Based on the Price/Forward Earnings ratio, ACA is valued cheaper than 83.64% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.82, ACA is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.19 | ||
| Fwd PE | 19.76 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 80.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ACA is valued a bit cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.75 | ||
| EV/EBITDA | 13.33 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACA's earnings are expected to grow with 22.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)5.85
EPS Next 2Y26.07%
EPS Next 3Y22.4%
5. Dividend
5.1 Amount
With a yearly dividend of 0.22%, ACA is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.66, ACA pays a better dividend. On top of this ACA pays more dividend than 81.82% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, ACA's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
5.2 History
The dividend of ACA decreases each year by -0.48%.
ACA has been paying a dividend for over 5 years, so it has already some track record.
ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
10.63% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP10.63%
EPS Next 2Y26.07%
EPS Next 3Y22.4%
NYSE:ACA (10/24/2025, 11:19:36 AM)
94.51
+1.45 (+1.56%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners95.34%
Inst Owner Change-0.29%
Ins Owners1.8%
Ins Owner Change6.34%
Market Cap4.63B
Revenue(TTM)2.68B
Net Income(TTM)92.20M
Analysts86
Price Target118.32 (25.19%)
Short Float %2.51%
Short Ratio4.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP10.63%
Div Incr Years0
Div Non Decr Years5
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.94%
Min EPS beat(2)17.65%
Max EPS beat(2)162.24%
EPS beat(4)3
Avg EPS beat(4)36.02%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)29.61%
EPS beat(12)11
Avg EPS beat(12)31.83%
EPS beat(16)15
Avg EPS beat(16)40.43%
Revenue beat(2)1
Avg Revenue beat(2)-0.94%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.83%
Revenue beat(4)1
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-7.1%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-0.98%
Revenue beat(12)7
Avg Revenue beat(12)0.67%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)0%
PT rev (3m)3.73%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0.04%
EPS NY rev (3m)4.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.6%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-0.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.19 | ||
| Fwd PE | 19.76 | ||
| P/S | 1.73 | ||
| P/FCF | 15.75 | ||
| P/OCF | 10.45 | ||
| P/B | 1.85 | ||
| P/tB | 5.51 | ||
| EV/EBITDA | 13.33 |
EPS(TTM)3.13
EY3.31%
EPS(NY)4.78
Fwd EY5.06%
FCF(TTM)6
FCFY6.35%
OCF(TTM)9.05
OCFY9.57%
SpS54.56
BVpS51.15
TBVpS17.14
PEG (NY)0.9
PEG (5Y)5.85
Graham Number60.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 3.68% | ||
| ROCE | 5.33% | ||
| ROIC | 4.09% | ||
| ROICexc | 4.27% | ||
| ROICexgc | 6.98% | ||
| OM | 8.93% | ||
| PM (TTM) | 3.45% | ||
| GM | 20.82% | ||
| FCFM | 11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 5.72 | ||
| Debt/EBITDA | 3.68 | ||
| Cap/Depr | 69.44% | ||
| Cap/Sales | 5.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.67% | ||
| Profit Quality | 319.09% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 2.16 |
F-Score5
WACC9.58%
ROIC/WACC0.43
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)2.62%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%39.56%
EPS Next Y33.6%
EPS Next 2Y26.07%
EPS Next 3Y22.4%
EPS Next 5YN/A
Revenue 1Y (TTM)9.78%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%10.86%
Revenue Next Year10.2%
Revenue Next 2Y8.19%
Revenue Next 3Y6.56%
Revenue Next 5YN/A
EBIT growth 1Y27.67%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year133.35%
EBIT Next 3Y37.6%
EBIT Next 5YN/A
FCF growth 1Y717.22%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y103.53%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
What is the valuation status for ACA stock?
ChartMill assigns a valuation rating of 5 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
Can you provide the profitability details for ARCOSA INC?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARCOSA INC (ACA) stock?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 30.19 and the Price/Book (PB) ratio is 1.85.
What is the expected EPS growth for ARCOSA INC (ACA) stock?
The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 33.6% in the next year.